Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
The Journal of Clinical Investigation published a comprehensive review showing that semaglutide does not increase thyroid or pancreatic cancer risk in human studies
doi: 10.2337/db15-0973 81 KanoskiSEFortinSMArnoldMGrillHJHayesMR
If in fact future studies robustly establish a beneficial effect of the drug class in HF, it may allow for broader adoption of GLP-1 RAs in the prevalent CVD, ultimately contributing to addressing the unmet medical need that continues to persist in the prevention or management of, in particular, HFpEF
KarakasisPPatouliasDTheofilisPPamporisKSagrisMVlachakisPKet al
US$ 21.56
US$ 28.21
US$ 23.20
US$ 20.42
US$ 20.08
US$ 20.38
US$ 23.45
